Delivery Order SPE2DR25D2018-SPE2DR26FZ1A0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,247.35 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) with a completion date of January 12, 2026. This firm fixed-price delivery order, awarded on January 9, 2026, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $17,047.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a direct fulfillment of pharmaceutical needs through AmerisourceBergen's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,118.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on January 6, 2026, with completion expected by January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $5,161.87 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,078.93 on January 20, 2026, to supply Jardiance 25 mg tablets (90-count) to the Defense Logistics Agency with an ultimate completion date of January 21, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Jardiance 10 mg tablets (90-count) valued at $11,906.66. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is due for completion by November 13, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,790.55 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on January 27, 2026, with an ultimate completion date of January 28, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $5,457.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $21,473.87 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 22, 2026, with completion scheduled for January 23, 2026. This competitive award, structured as a firm fixed-price delivery order with no set-aside designation, represents a task order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $15,594.53 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on January 20, 2026, with a completion date of January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical...
- SPE2DR25D2018Indefinite Delivery Contract
- SPE2DR25D2018-SPE2DR26FZ1A0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,096.96 to Amerisourcebergen Drug Corp (subsidiary of parent company Cencora, Inc.) on January 28, 2026, with completion scheduled for January 29, 2026. The contract covers the supply of Jardiance 10 mg tablets in quantities of 90 units and is structured as a firm fixed-price delivery order with no set-aside designation. The awardee's place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary distribution facility. This delivery order operates under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. Amerisourcebergen's federal contract portfolio demonstrates extensive capability in delivering specialty pharmaceuticals and medical commodities to defense and veteran healthcare programs across multiple therapeutic domains, with consistent competitively awarded contracts ranging from small-value orders to substantial pharmaceutical procurements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 1/27/26 |